Evaluation of balanced hydroxyethylstarch(HES 130/0.4) in upper abdominal surgery monitoring using the transpulmonal themodilution method: A prospective randomized trial

Evaluation of balanced hydroxyethylstarch(HES 130/0.4) in upper abdominal surgery monitoring using the transpulmonal themodilution method: A prospective randomized trial - A prospective randomized trial of evaluation of balanced hydroxyethylstarch(HES 130/0.4) using the transpulmonal themodilution method

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019930

Enrollment

Registered

2015-11-26

Start date

2015-11-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypovolemic state

Interventions

Insertion of a catheter into a central vein and femoral artery.Connection EV1000 monitor to a patient(about 1 day) Fluid resustation at hypovolemic state. crystalloid solution(+) Volven(-) Fluid resu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient that an upper abdominal surgery was planned

Exclusion criteria

Exclusion criteria: Patient of NYHA classification 3-4 degrees, Patient having a renal dysfunction or live dysfunction, postoperative Hb less than 9g/dl, something coagulopathy, operation history of respiratory organ, not cooperatively patient, other inappropriate patient.

Design outcomes

Primary

Measure	Time frame
Comparison of total fluid volume and extravascular lung water index in crystalloid solution or volven.	—

Secondary

Measure	Time frame
Whether or not the postoperative respiratory complication, and hospital stay.	—

Countries

Japan

Contacts

Public ContactSatoshi Kazuma

Sapporo medical university Department of Anesthesiology

sea_hawk_3104@yahoo.co.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026